Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
2000 2
2001 1
2002 1
2003 1
2008 6
2009 3
2010 2
2011 5
2012 8
2013 5
2014 6
2015 5
2016 4
2017 3
2018 4
2019 4
2020 4
2021 1
2022 7
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer.
Makker V, Colombo N, Casado Herráez A, Santin AD, Colomba E, Miller DS, Fujiwara K, Pignata S, Baron-Hay S, Ray-Coquard I, Shapira-Frommer R, Ushijima K, Sakata J, Yonemori K, Kim YM, Guerra EM, Sanli UA, McCormack MM, Smith AD, Keefe S, Bird S, Dutta L, Orlowski RJ, Lorusso D; Study 309–KEYNOTE-775 Investigators. Makker V, et al. N Engl J Med. 2022 Feb 3;386(5):437-448. doi: 10.1056/NEJMoa2108330. Epub 2022 Jan 19. N Engl J Med. 2022. PMID: 35045221 Clinical Trial.
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer.
von Minckwitz G, Huang CS, Mano MS, Loibl S, Mamounas EP, Untch M, Wolmark N, Rastogi P, Schneeweiss A, Redondo A, Fischer HH, Jacot W, Conlin AK, Arce-Salinas C, Wapnir IL, Jackisch C, DiGiovanna MP, Fasching PA, Crown JP, Wülfing P, Shao Z, Rota Caremoli E, Wu H, Lam LH, Tesarowski D, Smitt M, Douthwaite H, Singel SM, Geyer CE Jr; KATHERINE Investigators. von Minckwitz G, et al. N Engl J Med. 2019 Feb 14;380(7):617-628. doi: 10.1056/NEJMoa1814017. Epub 2018 Dec 5. N Engl J Med. 2019. PMID: 30516102 Clinical Trial.
Pembrolizumab versus Ipilimumab in Advanced Melanoma.
Robert C, Schachter J, Long GV, Arance A, Grob JJ, Mortier L, Daud A, Carlino MS, McNeil C, Lotem M, Larkin J, Lorigan P, Neyns B, Blank CU, Hamid O, Mateus C, Shapira-Frommer R, Kosh M, Zhou H, Ibrahim N, Ebbinghaus S, Ribas A; KEYNOTE-006 investigators. Robert C, et al. N Engl J Med. 2015 Jun 25;372(26):2521-32. doi: 10.1056/NEJMoa1503093. Epub 2015 Apr 19. N Engl J Med. 2015. PMID: 25891173 Free article. Clinical Trial.
Synthetic Cannabinoids.
Mills B, Yepes A, Nugent K. Mills B, et al. Among authors: yepes a. Am J Med Sci. 2015 Jul;350(1):59-62. doi: 10.1097/MAJ.0000000000000466. Am J Med Sci. 2015. PMID: 26132518 Review.
BioC interoperability track overview.
Comeau DC, Batista-Navarro RT, Dai HJ, Doğan RI, Yepes AJ, Khare R, Lu Z, Marques H, Mattingly CJ, Neves M, Peng Y, Rak R, Rinaldi F, Tsai RT, Verspoor K, Wiegers TC, Wu CH, Wilbur WJ. Comeau DC, et al. Among authors: yepes aj. Database (Oxford). 2014 Jun 30;2014:bau053. doi: 10.1093/database/bau053. Print 2014. Database (Oxford). 2014. PMID: 24980129 Free PMC article. Review.
177Lu-DOTATATE treatment in neuroendocrine tumours. A preliminary study.
Hervás I, Bello P, Falgas M, Del Olmo MI, Torres I, Olivas C, Vera V, Oliván P, Yepes AM. Hervás I, et al. Among authors: yepes am. Rev Esp Med Nucl Imagen Mol. 2017 Mar-Apr;36(2):91-98. doi: 10.1016/j.remn.2016.10.003. Epub 2016 Nov 23. Rev Esp Med Nucl Imagen Mol. 2017. PMID: 27889527 English, Spanish.
Use of complementary and alternative medicine by cancer patients in Colombia.
Murillo R, Pinto-Martínez N, Serrano N, Uribe C, Navarro E, Duque J, Yepes A, Olaya L, Mariño C, Morales OL, Erazo-Muñoz MA, Sánchez-Vega DC, Martínez-Ramos N. Murillo R, et al. Among authors: yepes a. BMC Complement Med Ther. 2023 Sep 14;23(1):321. doi: 10.1186/s12906-023-04144-z. BMC Complement Med Ther. 2023. PMID: 37710213 Free PMC article. Review.
69 results